2003 Gordon Conference on CAG Triplet Repeat Disorders
Project Number1R13NS045639-01
Contact PI/Project LeaderLEVINE, MICHAEL S.
Awardee OrganizationGORDON RESEARCH CONFERENCES
Description
Abstract Text
DESCRIPTION (provided by applicant): This application requests funding for the 2003 Gordon Research Conference on CAG triplet repeat disorders to be held in II Ciocco, Barga, Italy, May 4-9, 2003. This will be the second Gordon Research Conference on CAG repeat disorders, the first was held in 2001 at Mount Holyoke College, MA, USA. During the last decade, the mutation that causes a major group of inherited neurological disorders was found to be a CAG triplet repeat expansion. So far, this group of diseases includes Huntington's disease, the spinocerebellar ataxias 1, 2, 3, 6, 7 and 17, spinal and bulbar muscular atrophy and dentatorubral pallidoluysian atrophy. In each case, the CAG repeat lies within the coding region of the gene and results in an abnormally long polyglutamine tract in the mutant protein. Similarities in the underlying genetics and neuropathology suggest that the mechanisms of pathogenesis share common features. However, these diseases result in different anatomical distributions of the selective loss of neurons in the brain and spinal cord, and therefore the factors that distinguish them also need to be unraveled. Since the identification of the genetic defects, significant insights have been gained into the pathogenesis of these diseases. The field has progressed to the extent that the development of rational therapeutics is on the horizon. In order to increase the pace of the basic research, and at the same time set in place the contacts and clinical resources necessary to move the basic science into the clinic, a multidisciplinary research effort is required. It is essential that collaborative projects between scientists from diverse specialties ranging from organic chemistry, fruit fly genetics to clinical neurology can be established. This conference on CAG triplet repeat disorders will gather together young investigators and established senior scientists to deliver provoking lectures on the cutting-edge of science. In keeping with the Gordon Research Conference format, there will be generous time allocated for both structured discussions led by peers and for informal discussions and social interactions to facilitate collaborations. Strong emphasis is placed on training and mentoring of young scientists, and time will be devoted to career issues. All participants (except speakers and discussants) will be required to present posters. Priority will be given to women, minorities, and persons with disabilities when selecting participants.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
gene mutationmeeting /conference /symposiumnervous system disordertravel
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
075712877
UEI
XL5ANMKWN557
Project Start Date
01-May-2003
Project End Date
30-April-2004
Budget Start Date
01-May-2003
Budget End Date
30-April-2004
Project Funding Information for 2003
Total Funding
$40,000
Direct Costs
$40,000
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2003
National Institute on Aging
$10,000
2003
National Institute of Neurological Disorders and Stroke
$10,000
2003
NIH Office of the Director
$20,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R13NS045639-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R13NS045639-01
Patents
No Patents information available for 1R13NS045639-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R13NS045639-01
Clinical Studies
No Clinical Studies information available for 1R13NS045639-01
News and More
Related News Releases
No news release information available for 1R13NS045639-01
History
No Historical information available for 1R13NS045639-01
Similar Projects
No Similar Projects information available for 1R13NS045639-01